40,250 Albemarle Corporation $ALB Shares Acquired by Yousif Capital Management LLC

Yousif Capital Management LLC grew its position in Albemarle Corporation (NYSE:ALB) by 71.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 96,427 shares of the specialty chemicals company’s stock after acquiring an additional 40,250 shares during the period. Yousif Capital Management LLC’s holdings in Albemarle were worth $10,200,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in ALB. Sigma Planning Corp lifted its position in Albemarle by 2.3% in the first quarter. Sigma Planning Corp now owns 2,952 shares of the specialty chemicals company’s stock valued at $530,000 after purchasing an additional 66 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of Albemarle by 0.3% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 27,452 shares of the specialty chemicals company’s stock worth $4,928,000 after buying an additional 75 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Albemarle by 0.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 11,664 shares of the specialty chemicals company’s stock worth $2,082,000 after buying an additional 75 shares in the last quarter. Cadence Wealth Management LLC raised its stake in shares of Albemarle by 1.8% during the 1st quarter. Cadence Wealth Management LLC now owns 4,982 shares of the specialty chemicals company’s stock worth $894,000 after buying an additional 87 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its holdings in shares of Albemarle by 7.0% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,584 shares of the specialty chemicals company’s stock valued at $214,000 after buying an additional 103 shares during the period. 92.87% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ALB has been the topic of a number of analyst reports. Rothschild & Co Redburn decreased their price target on Albemarle from $188.00 to $170.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 1st. Mizuho raised Albemarle from a “neutral” rating to an “outperform” rating and set a $130.00 price objective on the stock in a report on Wednesday, October 14th. JPMorgan Chase & Co. cut their price objective on Albemarle from $160.00 to $140.00 and set a “neutral” rating for the company in a research report on Tuesday, August 25th. Zacks Research downgraded Albemarle from a “hold” rating to a “strong sell” rating in a report on Friday, October 9th. Finally, Royal Bank Of Canada reduced their target price on Albemarle from $157.00 to $129.00 and set an “outperform” rating for the company in a report on Thursday, October 15th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $179.41.

Albemarle Trading Up 1.3%

Shares of ALB opened at $93.72 on Friday. The company has a current ratio of 2.09, a quick ratio of 1.35 and a debt-to-equity ratio of 0.22. The firm’s 50-day moving average is $115.66 and its two-hundred day moving average is $142.77. Albemarle Corporation has a twelve month low of $88.01 and a twelve month high of $221.00. The firm has a market capitalization of $11.06 billion, a P/E ratio of 347.14, a PEG ratio of 0.56 and a beta of 1.36.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.20 by $0.55. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same period last year, the company posted $0.11 earnings per share. The firm’s quarterly revenue was up 31.1% compared to the same quarter last year. On average, research analysts predict that Albemarle Corporation will post 11.19 earnings per share for the current fiscal year.

Albemarle Profile

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.